Scopolamine Market

Scopolamine Market INDUSTRY INSIGHTS, TRENDS, OUTLOOK, AND
OPPORTUNITY ANALYSIS, 2016–2024
© Coherent market Insights. All Rights Reserved
REPORT DESCRIPTION
Scopolamine Market : Overview
Scopolamine is an alkaloid drug extracted from plant called henbane to treat nausea
and motion sickness and further to dilate the pupil in ophthalmic procedures.
Scopolamine belongs to a class of drugs called anticholinergics. It works by
blocking the activity of the neurotransmitter acetylcholine, which stimulates the part
of the brain that triggers nausea and vomiting, involuntary muscle movement in the
lungs, and the gastrointestinal and urinary tracts.
Scopolamine is also used in medicine as a sedative or hypnotic and sometimes with
morphine to relieve pain. Scopolamine has also been prescribed ‘off label’ for
depression, asthma, as a smoking-cessation remedy, and to relieve the nausea that
accompanies chemotherapy.
The global scopolamine market size was valued at US$ 370.4 million in 2017, and
is expected to witness a CAGR of 4.8% over the forecast period (2018 – 2026).
© Coherent market Insights. All Rights Reserved
REPORT DESCRIPTION
Scopolamine Market : Taxonomy
•
This report provides in-depth analysis of the scopolamine market, market size
(US$ Mn) and cumulative annual growth rate (CAGR (%)) for the forecast
period: 2018 – 2026, considering 2017 as the base year
•
•
This study also provides key insights about market drivers, restraints,
opportunities, new product launches or approval, market trends, regional outlook,
and competitive strategies adopted by the leading players
It profiles leading players in the global scopolamine market based on the
following parameters – company overview, financial performance, product
portfolio, geographical presence, distribution strategies, key developments, and
strategies
Request A Sample Copy@
https://www.coherentmarketinsights.com/insight/request-sample/1965
© Coherent market Insights. All Rights Reserved
REPORT DESCRIPTION
Scopolamine Market: Key Players
●
●
●
●
●
●
●
●
●
●
●
Baxter International Inc.
GlaxoSmithKline plc
Novartis AG
Perrigo Company plc
Caleb Pharmaceuticals, Inc.
Myungmoon Pharma Co. LTD.
Alchem International
Phytex Australia
Centroflora-Cms
Alkaloids of Australia
Fine Chemicals Corporation.
Get More Information@
https://www.coherentmarketinsights.com/market-insight/scopolamine-market-1965
© Coherent market Insights. All Rights Reserved
ABOUT COHERENT MARKET INSIGHTS
ABOUT US
Coherent Market Insights is a global market intelligence and consulting
organization focused on assisting its plethora of clients achieve transformational
growth by helping them make critical business decisions. We are headquartered in
India, with an office at the global financial capital in the U.S. Our client base
includes players from across all business verticals in over 150 countries worldwide.
We are uniquely positioned to help businesses around the globe deliver practical
and lasting results through various recommendations about operational
improvements, technologies, emerging market trends and new working methods.
We offer both customized and syndicated market research reports that help our
clients create visionary growth plans to provide traction to their business. We
meticulously study emerging trends across various industries at both the global and
regional levels to identify new opportunities for our clientele.
SERVICES
INDUSTRY ANALYSIS
MARKET INTELLIGENCE
SERVICES
© Coherent market Insights. All Rights Reserved
CUSTOMIZED
RESEARCH
CONSULT STUDIES
SYNDICATED RESEARCH
COUNTRY SPECIFIC
STUDIES
ABOUT CMI
SECTOR
COVERAGE
BIOTECHNOLOGY
CLINICAL
DIAGNOSTIC
MEDICAL DEVICES
MEDICAL
IMAGING
OUR CLIENTS








Global Leading Equipment and System Manufacturers
Component Providers and System Integrators
Distributors, Retailors and Value Added Resellers
Healthcare IT Solutions Developers
Marketing Consultancies and the Advertising Industry
Private and Government organization
Outsourcing Companies
Universities and Business Schools.
© Coherent market Insights. All Rights Reserved
HEALTHCARE IT
PHARMACEUTICAL
ABOUT COHERENT MARKET INSIGHTS
KEY STATS
RESEARCH SOLUTIONS
FEASIBILITY
STUDIES
GLOBAL
REPORTS
100+
Insights Published Per
Year
150+
Consulting Projects Till Date
125+
COUNTRY
ANALYSIS
CONSULT
PROJECTS
SURVEY
RESEAR
CH
EXCEL
FORECAST
DATABASE
COMPETITIVE
ASSESSMENT
Clients Worldwide Per Year
110+
TECHNOLOGY
SNIPPETS
Analysts and Contract Consultants
Coherent Market Insights excels at offering unmatched actionable market intelligence across various industry verticals, including
chemicals, healthcare, and food & beverages, to name a few. We implement holistic market research methodology in order to result in
the best possible market research reports across various industries worldwide. Based on our unmatched expertise across various
industries—no matter how large or small, how complex or unique—we help our clients achieve better outcomes with uniquely
designed and highly customized solutions. Our coverage includes insights that help our clients ensure sustained growth in developed
markets and also key inputs to help them tap into emerging markets and exploit the plethora of opportunities posed therein.
© Coherent market Insights. All Rights Reserved
THANK YOU
To know more about us, visit our website:
www.coherentmarketinsights.com
For sales queries or new topics email us on:
[email protected]
For other queries contact:
Mr. Shah
(Manager - Business Development)
Coherent Market Insights
[email protected]
+1-206-701-6702
© Coherent market Insights. All Rights Reserved

Psychological stress is considered as one of the most important factors in the development of motion sickness. The psychological stress impacts intestinal motility, intestinal sensitivity, permeability, and secretion that is co-related with the mucosal immune activation and alterations in the central nervous system.

Download Report